1Y Close · As of Aug 26, 2026
GC Medical Science operates in the Pharmaceuticals sector.
Legal name: GC Medical Science Corporation
In fiscal year 2025, GC Medical Science (142280) reported revenue of 108.4 billion KRW, up 4.4% from 103.9 billion KRW a year earlier.
Operating profit was 2.9 billion KRW and net income was 3.5 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 71.1 billion KRW, with a P/B of 1.53.
These figures can be verified in the DART filing (receipt no. 20260316001623).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 108.4B | 2.9B | 3.5B |
| 2024 | 103.9B | 2.3B | 3.4B |
| 2023 | 94.0B | 1.8B | 1.9B |
Recent Filings
Semi-Annual Report (2026.06)
Large Shareholding Report (Simplified)
Consolidated Operating (Preliminary) Earnings (Fair Disclosure)
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-07 | Large Shareholding Report (Simplified) |
| 2026-07-31 | Consolidated Operating (Preliminary) Earnings (Fair Disclosure) |